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Abstract
Objective: Vascular smooth muscle cell (VSMC) hypertrophy and proliferation occur in response to strain-induced
local and systemic inflammatory cytokines and growth factors which may contribute to hypertension,
atherosclerosis, and restenosis. We hypothesize VSMC strain, modeling normotensive arterial pressure waveforms in
vitro, results in attenuated proliferative and increased hypertrophic responses 48 hrs post-strain.
Methods: Using Flexcell Bioflex Systems we determined the morphological, hyperplastic and hypertrophic responses
of non-strained and biomechanically strained cultured rat A7R5 VSMC. We measured secretion of nitric oxide, key
cytokine/growth factors and intracellular mediators involved in VSMC proliferation via fluorescence spectroscopy and
protein microarrays. We also investigated the potential roles of VEGF on VSMC strain-induced proliferation.
Results: Protein microarrays revealed significant increases in VEGF secretion in response to 18 hours mechanical
strain, a result that ELISA data corroborated. Apoptosis-inducing nitric oxide (NO) levels also increased 43% 48 hrs
post-strain. Non-strained cells incubated with exogenous VEGF did not reproduce the antimitogenic effect.
However, anti-VEGF reversed the antimitogenic effect of mechanical strain. Antibody microarrays of strained VSMC
lysates revealed MEK1, MEK2, phospo-MEK1
T385, T291, T298, phospho-Erk1/2
T202+Y204/T185+T187, and PKC isoforms
expression were universally increased, suggesting a proliferative/inflammatory signaling state. Conversely, VSMC
strain decreased expression levels of Cdk1, Cdk2, Cdk4, and Cdk6 by 25-50% suggesting a partially inhibited
proliferative signaling cascade.
Conclusions: Subjecting VSMC to cyclic biomechanical strain in vitro promotes cell hypertrophy while attenuating
cellular proliferation. We also report an upregulation of MEK and ERK activation suggestive of a proliferative
phenotype. Hhowever, the proliferative response appears to be aborogated by enhanced antimitogenic cytokine
VEGF, NO secretion and downregulation of Cdk expression. Although exogenous VEGF alone is not sufficient to
promote the quiescent VSMC phenotype, we provide evidence suggesting that strain is a necessary component to
induce VSMC response to the antimitogenic effects of VEGF. Taken together these data indicate that VEGF plays a
critical role in mechanical strain-induced VSMC proliferation and vessel wall remodeling. Whether VEGF and/or NO
inhibit signaling distal to Erk 1/2 is currently under investigation.
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oxide
Introduction
Cyclic strain (CS) induced by changes in blood pressure
can regulate vascular remodeling, proliferation, apoptosis,
cell phenotypic changes, and secretion of extracellular
matrix proteins and cytokines [1]. Pathological states such
as hypertension, atherosclerosis, and restenosis lead to
further changes in vascular remodeling [1]. Vascular
smooth muscle cells (VSMC) are prevalent in vessel walls
and are mechanotransducers of strain and shear stress [2].
In vitro biophysical strain models that mimic arterial pres-
sure waveforms have provided important mechanistic
explanations about VSMC responses [2,3]. For instance,
under normotensive conditions, hemodynamic forces
strain large arteries up to 10% (termed “physiological”
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any medium, provided the original work is properly cited.strain; [4]), which shifts VSMC from a synthetic/secretory
phenotype in static culture to a non-proliferative contrac-
tile phenotype [5-7]. Further elevation of strain magnitude
(15 - 30%) [4] shifts cells to a contractile proliferative phe-
notype [7].
Mechanotransduction cascades have been implicated in
the regulation of the VSMC proliferative response [2]
including VSMC-derived cytokines such as IGF-1 and
PDGF [8-10]. Vascular endothelial growth factor (VEGF)
is also an important repressor of VSMC proliferation
[11,12], and is upregulated in aorta from hypertensive
rats [13] and in strained VSMC cultures [14]. VSMC
calcium homeostasis also plays a pivotal role in strain-
induced VSMC proliferation which is dependent upon
both stretch activated calcium channels (SACC) and
voltage operated calcium channels [15]. Thus the prolif-
erative effects of biomechanical strain on VSMC are
dependent upon the complex interplay of the intracellu-
lar signaling cascades involved in proliferation and pro-
gression of the cell cycle.
The current study investigates the antimitogenic effects
of a 10% CS on VSMC. We assessed strain-regulation of
autocrine cytokine and growth factor secretion and
hypothesized that VEGF plays an important role in med-
iating strain-induced antimitogenic behavior. We also
examined the potential role of SACCs in mediating this
antiproliferative effect and the expression and phosphory-
lation of the mechanosensitive ERK1/2 signaling cascade,
PKC isoforms, and Cdk isoforms.
Materials and methods
Vascular Smooth Muscle Cell Cultures
A7r5 rat thoracic aortas VSMC were purchased from
American Type Culture Collection (Rockville, MD). Cells
were cultured in Dulbecco’s modified Eagles Medium
(DMEM) supplemented with 9% fetal bovine serum (FBS)
and 1% penicillin-streptomycin at 37°C, 5% CO2,a n d
100% humidity. Growth medium (GM) was replaced every
other day, and upon 80% confluency cells were passed at a
ratio of 1 to 4 (acquired in 4 to 5 days). All experiments
utilized passage-matched VSMC between passage 2
and 10.
In Vitro Strain Apparatus
The Flexercell FX-4000 Tension Plus (Flexcell Interna-
tional Corp, Hillsborough, NC) is a computer-based sys-
tem which utilizes vacuum suction to strain cells seeded
on flexible collagen I-coated electrometric membranes.
The deformation of the elastomeric membrane causes the
adherent cells to similarly deform. The strain profile was
created by programming the magnitude, duration, and fre-
quency of negative pressure to match the desired model.
Strain on the cells utilizing this apparatus has been empiri-
cally determined to be heterobiaxial [16].
Strain Profile
Cells were seeded (65,000 cells/well) onto 6-well collagen
I-coated Bioflex plates (Flexcell International Corp,
Hillsborough, NC). Once the cells were ~50-60% conflu-
ent (~24 hours after seeding), the GM was replaced with
serum-free medium for 24 hours to induce quiescence,
and on the day of the experiment the medium was
replaced with fresh GM. VSMC were then cyclically
strained for 1, 6, 18 or 48 hours. The strain paradigm
modeled an aortic pressure w a v e f o r ma n di n c l u d e da
modeled dicrotic notch (Figure 1 top). Control cells were
grown in the identical environment, but were not sub-
jected to strain.
Cell viability, growth assessments, and morphology
A subset of control and strained cells was lysed and cell
lysates were used for dsDNA (Invitrogen Corporation;
Eugene, OR) and protein quantification (Pierce Chemical
C o . ,R o c k f o r d ,I L ) .T h er a t i oo fp r o t e i nt od s D N Aw a s
calculated as one proxy of cellular hypertrophy. Phase
contrast microscopy at 48 hours was used to quantify cell
viability, cell number, cell area and perimeter, and mor-
phologic changes. Actin architecture changes were
assessed using rhodamine-conjugated phalloidin as pre-
viously described [17]. Photomicrographs were digitally
captured using an IX71 Olympus inverted fluorescent
microscope and DP71 camera (Olympus America Inc,
Melville, NY) and cell area and perimeter measure
obtained via Image J v1.37 (National Institute of Health;
http://rsb.info.nih.gov/ij/). Cells were randomly selected
from four representative experiments and at least four
cells from each photographic quadrant were measured in
blinded fashion (control: n = 17; strain: n = 16). Cells per
high powered field (cells/hpf) were calculated from digital
images of control (n = 24) and strained (n = 27) cells
from four experiments.
Cytokine Detection
Conditioned media samples obtained from six control
and strained samples were collected at the end of
48 hours and frozen at -80°C until assayed. Array mem-
branes were prepared and percent change from control
(%CFC) was determined by methods described previously
[18]. Further assessment of VEGF was done using a rat
enzyme-linked immunosorbent assay (ELISA) kit (Ray-
biotech Inc., Norcross, GA). VSMC strain-derived NO
was quantified using a fluorometric assay kit, (Cayman
Chemical Company, Ann Arbor, MI). All data were nor-
malized to cell proliferation data.
Exogenous VEGF Experiments
In a subset of experiments, quiescent medium was
replaced with 100 μl of GM containing rat VEGF (R&D
Systems, Minneapolis, MN) concentrations of 0, 0.003,
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Page 2 of 100.03, 0.3, 3, and 30 ng/ml. Cells were then incubated for
an additional 18 or 48 hours and proliferation rates at
these two time points were measured using the CellTi-
ter 96
® Aqueous One Solution Cell Proliferation Assay
(MTS). Neither control nor VEGF-treated VSMC were
strained in this experimental series. In a separate set
of experiments, control and strained VSMC were trea-
ted with 0.4 μg/ml of anti-VEGF (R&D Systems,
Top
Bottom
Figure 1 Aortic Pressure Waveform Regulates VSMC Alignment: (Top Panel) Strain profile used in this study. Control cells were not strained.
(Bottom Panel) Control VSMC (A, C) and VSMC strained cyclically for 48 hours at 1 Hz, 10% (B, D). Representative wells in each experimental group
were fluorometrically stained for assessment of intracellular actin (A, B). Arrows in panel B indicate the direction of the dominant strain vector.
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method previously described.
Effects of Extracellular Calcium and Gadolinium
In a subset of experiments, serum-free medium was
replaced with one of the following growth media contain-
ing 9% FBS: 1) Hyclone custom calcium-free medium
(CFM; Thermo Scientific Hyclone AdvanceStem, Logan,
UT) with 0.0018 moles/L CaCl2, 2) CFM with 0.0018
moles/L NaCl (osmotic control), and 3.) CFM with
0.0018 moles/L CaCl2 and 30 μMo fG d C l 3. Cells were
then strained or left static for 48 hours.
Intracellular Protein Microarrays
Antibody microarray services from Kinexus Bioinformatics
Corporation (Vancouver, BC, Canada) detected the
expression and phosphorylation states of 608 cell signaling
proteins (in duplicate) after 48 hours strain from 10 cul-
ture wells of control and strained VSMC. Samples were
prepared per Kinexus protocol; five wells were collectively
pooled for each assay based upon the media and protein
requirements for detection. Protein spotting and hybridi-
zation onto the array, scanning, imaging, and quantitative
analysis of the enhanced chemiluminescence signal of the
signaling proteins was performed (in a blinded fashion) by
Kinexus Bioinformatics Corporation. Only proteins exhi-
biting a %CFC of ± 25% were considered for further
analysis.
Replicates and statistical analysis
Experiments were completed a minimum of three times
and had three or more replicate wells per experiment,
except for the anti-VEGF and calcium/gadolinium experi-
ments which was completed over two experiments with
three or more replicate wells. Kinexus antibody microarray
experiments consisted of ten pooled replicate wells and
the assay was done in duplicate. All data are expressed as
mean ± SEM and means were compared by two-tailed
unpaired t-tests or one-sample two-tailed t-tests where
appropriate. We tested for polyploidy (dsDNA:cell) by cal-
culating the variance of ratios [19] between the mean ±
SEM dsDNA and the mean ± SEM cells per high powered
f i e l df o rb o t hs t r a i n e da n dn o ns t r a i n e dV S M C ;p<0 . 0 5
were determined to be significantly different. All data were
analyzed with Microsoft Excel (Microsoft Corporation)
and Prism 4.03 (GraphPad Software, Inc., San Diego,
California).
Results
Intracellular actin and long axes of strain-induced VSMC
cytoskeleton aligned nearly perpendicularly to the domi-
nant strain vector (Figure 1; bottom panels B and D).
Non-strained VSMC displayed no such alignment char-
acteristics (Figure 1; bottom panels A and C). Strained
VSMC also exhibited decreased proliferation and
increased cell size versus control. Strained cells had
an average of 37% greater area (p < 0.05), 36% larger peri-
meter (p < 0.001) and 38% fewer cells/hpf (p < 0.001)
when compared to control after 48 hours of CS (Figure
2A-C). Double-stranded DNA concentration (Figure 2D)
was also reduced by 33% in strained VSMC (p < 0.001).
To confirm this dsDNA reduction was not a function of
cellular polyploidy as is common among hypertensive
VSMC, we calculated the concentration dsDNA:cells/hpf
ratio of strained vs. control (0.181 ± 0.016 μg DNA/cell
vs. 0.167 ± 0.056 μg DNA/cell) and determined there was
no significant difference (p > 0.05). Strained VSMC
exhibited an 18% increase in total cell protein (p < 0.01;
Figure 2E) and a 12% higher protein to DNA ratio (proxy
of hypertrophy) at 18 hours (p < 0.05) and 46% at
48 hours (p < 0.001). We also calculated the protein con-
centration:cells/hpf ratio of strained vs. control (56.4 ±
4.0 μg protein/cell vs. 28.8 ± 2.8; μg protein/cell p < 0.05)
a n di nt h i sc a s ew ef o u n dt h e r et ob eas i g n i f i c a n t
difference.
Compared to control cells at 48 hours, strained VSMC
exhibited significant changes in the secretion of CINC-3,
CNTF, Fractalkine, GM-CSF, IL-1b,I L - 4 ,I L - 6 ,L e p t i n ,
MCP-1, b-NGF and VEGF (p < 0.05 for all; Figure 3).
Further analysis of VEGF secretion via ELISA showed a
57% (p < 0.05) increase after 18 hours strain and 22%
increase (p > 0.05) after 48 hours strain when compared to
their respective controls (Figure 4A). VSMC also secreted
65% more NO after 48 hours of CS compared to control
(p < 0.05; Table 1).
In the absence of strain, 18 and 48 hours incubation
with various concentrations of exogenous VEGF did not
affect VSMC proliferation when compared to control
(Figure 4B). However, the addition of 0.4 μg/ml anti-
VEGF (100 times neutralizing dose, 50%) to VSMC prior
to a CS regimen caused a 29% increase (p < 0.01) in prolif-
eration accompanied by 26% decrease in protein expres-
sion (p < 0.05) compared to strained VSMC without anti-
VEGF (Figure 4C). Lower concentrations of anti-VEGF
( 0 . 0 0 4a n d0 . 0 4u g / m l )w e r et e s t e d ,b u td i dn o tr e s u l ti n
significant effects (results not shown). Importantly, anti-
VEGF also did not significantly affect proliferation or pro-
tein expression in non-strained control cells.
There were no differences in proliferation among VSMC
incubated with extracellular calcium, with calcium plus the
SACC inhibitor GdCl3, or in the absence of extracellular
calcium (osmotically controlled with Na+) after 48 hours
strain. When compared to non-strain VSMC, proliferation
among all strain groups were significantly decreased
(Table 1).
Antibody protein microarrays of VSMC lysates
revealed 46 cellular proteins and/or protein phosphory-
lation states that changed ± 25% from control (Table 2).
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Page 4 of 10Of interest, MAPK cascade peptides including MEK1,
MEK2, phospo-MEK1
T385, T291, S298, and phospho-Erk1/
2
T202+Y204/T185+T187 were universally increased in
strained VSMC compared to control. PKCl/τ,p h o s p o -
PKCl/τ
T555,P K C ζ,P K C θ,p h o s p o - P K C θ
S695,P K C μ,
phospo-PKCh
T655,P K C ε,p h o s p o -P K C δ
S645 were also
universally elevated compared to control. However,
Cdk4, Cdk6, phospo-Cdk1/2
T14+T15, and Cdk2 were all
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Figure 2 Strain Regulation of VSMC Hyperplasia and Hypertrophy: VSMC area (A), perimeter (B), and cells per high power field (hpf; panel
C) data from control (N = 17) and strained (N = 16) cells. Proliferation index (D), cellular protein (E), and protein/DNA ratio (F) data for control
(open symbols) and strained (closed symbols) VSMC. N = 6 to 9 per group; *p < 0.05; ***p < 0.001 vs. control at the same time point.
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Figure 3 Strain Regulation of VSMC Cytokine Secretion: Changes in cytokine levels in conditioned media from control and strained VSMC.
(A) Representative matched protein microarrays from control (left) and strained (right) groups. VEGF signals have been enlarged for clarity. (B)
Summary data for six protein microarrays showing percent change from control in cytokine levels *p < 0.05 vs. %CFC > 25%;
#p < 0.05 vs. %CFC
> 50%. All data are corrected on a per-cell basis. CINC-2 (cytokine induced neutrophil chemoattractant-2), CINC-3 (cytokine induced neutrophil
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Page 6 of 10decreased in cell lysates of strained versus control
(Table 2).
Discussion
Our study shows that cyclic strain (CS) causes an anti-
mitogenic response in VSMC, changes to actin/cell
alignment, hypertrophy, and strain-regulated cytokine
secretion. Secretion of NO and VEGF, among other
cytokines, are up-regulated in strained cells temporally
corresponding to the observed decreases in proliferation.
While exogenous VEGF alone (in the absence of strain)
does not inhibit proliferation, neutralization of VEGF
secreted from strained cells is effective in restoring nor-
mal proliferative responses in physiologically strained
VSMC. These data suggest that VEGF is necessary, but
is not sufficient to cause the antiproliferative effects
seen with CS. The antimitogenic intracellular signaling
mechanisms responsible are extracellular calcium-inde-
pendent, but potentially mediated by downregulation of
Cdks.
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Figure 4 Effects of Strain on VEGF Secretion and VEGF Blockade on VSMC Proliferation: (A) Temporal changes in VEGF secretion from
control (open symbols) and strained VSMC. N = 5 per group; * p ≤ 0.05 vs. control at same time point. (B) Lack of significant effects of 18 hours
(closed symbols) and 48 hours (open symbols) of exogenous VEGF treatment on proliferation in unstrained VSMC (N = 9). (C) Effects of strain
(closed bars) and anti-VEGF treatment on VSMC proliferation. N = 6; *p < 0.05 vs strain only group; **p < 0.01 vs strain only group.
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Page 7 of 10VSMC and their major actin stress fibers aligned
nearly perpendicular to the dominant strain vector after
48 hours of CS, a response which is consistent with our
previous findings [20]. In the absence of serum, we
found alignment was dependent on strain and autocrine
NO signaling [20]. Here we report similar findings in
the presence of serum, suggesting that VSMC actin
alignment is dependent upon CS and NO, but indepen-
dent of serum-derived growth factors and cytokines pre-
sent within the media prior to strain. We found VSMC
exhibited a hypertrophic response to strain evidenced by
significantly increased protein:DNA ratio (Figure 2D)
and increases in area and perimeter (Figure 2A-B).
These data are consistent with in situ studies which also
suggest a hypertrophic response in strained VSMC
[21,22].
CS causes an antimitogenic response in VSMC’s( F i g -
ure 2D and 4C). While we take into account VSMC in a
uniculture-only model, such a response in vivo would
cause leaky blood vessels with poor VSMC coverage
[23]. In vivo, VSMC proliferation is likely influenced by
other factors such as PDGF and IGF-1 released by
endothelial cells [24] to maintain a growth equilibrium
between strain induced anti-mitogenesis and paracrine
mediated VSMC proliferation. While we recognize that
other cell types can influence VSMC proliferation, for
t h i ss t u d yw ew e r ei n t e r e s t e do n l yi ns o l u b l em e d i a t o r s
secreted by VSMC in response to strain that may self-
regulate VSMC proliferation through an autocrine
mediated manner.
Autocrine cytokines have been implicated in strain-
induced hyperplasia (e.g., VEGF, IGF-1, PDGF, angioten-
sin II). We and others have found that some autocrines
may be alternatively regulated in response to strain
duration and magnitude. Quinn et al. has shown that a
15% equiradial strain increased the synthesis of VEGF
mRNA, while a 25% equiradial strain had no affect
VEGF mRNA [25]. This same group reported that while
VEGF mRNA expression increases significantly after
24 hrs of strain, there was no difference when compared
to non-strain cells after 48 hours strain [25]. We similarly
observed a 1.8 fold increase in VEGF secretion at 18 hours
which then leveled to control at 48 hours (Figure 4A). The
addition of anti-VEGF polyclonal antibody was sufficient
to reverse VSMC antimitogenic response to strain (Figure
4C) suggesting that VEGF is indeed a key mediator in the
VEGF antiproliferative response. Others have shown in
vitro exogenous VEGF (30 - 100 ng/ml) inhibits VSMC
proliferation in static conditions [11,26] possibly though
inhibition of MEK1/2 - ERK1/2 phosphorylation. How-
ever, exogenous incubation of VEGF at concentrations
approximate to secretory levels expressed in our model
(0.03 ng/ml) was insufficient to inhibit proliferation in
non-strain cultures (Figure 4B). This suggests that strain
itself is an important cofactor in VEGF-induced antimito-
genesis. Secretions of several other cytokines were
Table 1 Temporal changes in NO secretion from control and strained VSMC
Nitric Oxide (nM/ng DNA) Proliferation Index
Time (hours) Control Strain Treatment [DNA]/(ug/ml)
1 0.13 ± 0.013 0.13 ± 0.014 Control + Ca 6.28 ± 0.69
6 0.09 ± 0.025 0.10 ± 0.016 Strain + Ca 2.98 ± 0.66 **
18 0.12 ± 0.016 0.14 ± 0.013 Strain - Ca 3.30 ± 0.70 *
48 0.07 ± 0.009 0.12 ± 0.013
# Strain + Ca + GdCl3 2.62 ± 0.37 ***
N = 5 per group;
#p ≤ 0.05 vs. control at same time point. The effects of strain, calcium-free media and GdCl3 on VSMC proliferation. N = 6; *p < 0.05 vs. Control
+ Ca, **p < 0.01 vs. Control + Ca, ***p < 0.001 vs. Control + Ca; all values are expressed as mean ± SEM.
Table 2 Effects of strain on VSMC intracellular signaling
MEK1/ERK PKC CDK
Protein %CFC Protein %CFC Protein %CFC
MEK1 +148% PKC l/ι +41.4% Cdk4 -26%
MEK1
T385 +68.1% PKC l/ι
T555 +90.3% Cdk6 -39.3%
MEK1
T291 +159% PKC ζ +87% Cdk1/2
T14+Y15 -50%
MEK1
S298 +62% PKC θ +231% Cdk2 -49.6%
MEK2 +188.1% PKC θ
S695 +44.6%
ERK
T202+Y204/T185+Y187 +130% PKC μ +97.3%
PKC ε +30%
PKC δ +40.5%
%CFC = % change from control (non-strained) cells; T = threonine phosphorylation at sites stated, S = serine phosphorylation at sites stated. N = 10 pooled
samples for each treatment group. MEK = MAPK/ERK kinase protein-serine kinase; MAPK = mitogen-activated protein-serine kinase; ERK = extracellular regulated
protein-serine kinase; PKC = protein-serine kinase; CDK = cyclin-dependent protein-serine kinase.
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Page 8 of 10upregulated in response to strain with documented roles
in mediating both VSMC pro- and anti-mitogenic
response; pro-inflammatory cytokines CINC-3, CNTF,
Fractalkine, GM-CSF, IL-1b, IL-6, MCP-1, and BETA-
NGF; anti-inflammatory cytokines IL-4 and IL-10; VEGF
and leptin (Figure 3). The antiproliferative response we
observed likely culminates from a balance among both
pro- and anti-mitogenic cytokines working alongside
VEGF. Exploring whether antimitogenesis is due to strain
per se or resultant autocrine growth factors/cytokines in
our experiments is to be determined.
Intracellular transmission of mechanical strain stimuli
that induce VSMC mitogenic responses are highly depen-
dent on the mitogen activated protein kinase (MAPK) cas-
cade [1]. Mechanical strain is known to activate all three
members of the MAP kinase cascade: ERK1/2, JNKs, p38
MAPK [27,28]. Our results indicate that neither the JNK
nor p38 MAPK were elevated during strain, suggesting
these two signaling cascades were not activated by our
strain paradigm (results not shown). However, our results
did show ERK1/2 signaling cascade activation through
MEK phosphorylation at threonines 385 and 291, and ser-
ine 298. These sites have been previously shown to induce
MEK activation [29]. MEK1/2 then activate downstream
ERK1/2 by phosphorylating ERK threonines 202 and 185
and ERK tyrosines 204 and 187 [30-32]. This is consistent
with our findings of increased ERK1/2 phosphorylation at
these sites (Table 2). Furthermore, protein kinase C (PKC)
is also a key upstream regulator of ERK1/2 [33] which was
also found to be upregulated in response to strain. This
study shows 48 hours of CS activates PKC θ and δ by
phosphorylation at serine 695 and serine 645 respectively
and activates [34] atypical PKC l/ι by phosphorylation of
threonine 555 (Table 1). Although MAPK and PKC play
important roles in strain-induced VSMC proliferation, the
outcome of these signaling cascades, and thus progression
through the cell cycle, is ultimately regulated by cyclin-
Cdk complexes inside the cell nucleus which may be regu-
lated in part by NO.
NO is a key mediator of the antimitogenic response
which down regulates the expression of several Cdks [35].
Our previous studies have shown that NO is activated
through the inducible nitric oxide synthase (iNOS) path-
way during CS in VSMC cultured without serum [20].
Our latest results show NO production is significantly ele-
vated vs. control (71%) after 48 hours of strain in the pre-
sence of serum (Table 1). This suggests that NO increases
are strain-dependent and serum factor-independent.
While our observed decrease in VSMC proliferation
appears to be partially attributed to VEGF (Figure 4C), co-
regulation by iNOS may also play a central role in strain-
induced anti-proliferative response of VSMC.
Proliferation requires the expression of cyclin depen-
dent kinases (Cdks) and our results show decreased
expression of Cdk2, Cdk4, and Cdk6 after 48 hours of
strain (Table 2). Decreased proliferation due to
decreased expression of Cdk has been identified for
VSMC suggesting that strain may be acting through a
Cdk inhibitory pathway. NO-mediated downregulation
of Cdk2 activity and cyclin A gene transcription [35]
may help to explain our results which show a decrease
in strain-induced VSMC proliferation despite MAPK
and ERK1/2 upregulation. Decreased expression of both
Cdk4 and Cdk6 also suggests attenuated numbers of
cyclin D/Cdk4, Cdk6 complexes, and hence a slowing of
VSMC movement past the G0/1 restriction point. Our
results also showed a decrease in the phosphorylation of
Cdk1/2 at threonine 14 and tyrosine 15 (Table 2). These
two phosphorylation domains are critical for the inhibi-
tion of cyclin/Cdk complexes [36] suggesting a lack of
proliferative inhibition via this mechanism. However, the
down-regulation of Cdks 2, 4, and 6 in response to
strain appears to override the mitogenic effect of
decreased phosphorylation of Cdk1/2 resulting in a
decrease in VSMC proliferation.
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